EET that has been increased by the inhibition of soluble epoxide hydrolase exerts nephropathic effects, such as hypertensive renal damage, diabetic nephropathy, and obstructive nephropathy (Kim et al., 2015). Here, EPHX2 is linked to diabetic kidney disease.